Skip to content
PICO Portalanswers from OpenAlex

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas

PaperCitations, authors & open-access status

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas is a paper indexed in PICO Portal from OpenAlex.

How many citations does Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas have?

PICO Portalcitation count

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas has 99 citations in the OpenAlex counts PICO Portal stores.

When was Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas published?

PICO Portalyear

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas has 2015 year in the PICO Portal index.

What is the open-access status of Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas?

PICO Portaloa status

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas has closed oa status in the PICO Portal index.

What is the DOI of Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas?

PICO Portaldoi

The DOI for Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas is on the source record.

What is the PMID of Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas?

PICO Portalpmid

The PMID for Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas is on the source record.

What is the OpenAlex record for Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas?

PICO Portalopenalex

The OpenAlex for Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial